Mesocaine

Lidocaine Hydrochloride, the active ingredient in Mesocaine, is a Local anesthetic presented as a sterile solution for epidural, infiltration, and intravenous use. It provides rapid onset of local anesthesia and is employed in various surgical and pain‑management settings.

GNH USA supplies Mesocaine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and surgical centres worldwide, ensuring quality‑controlled manufacturing and reliable distribution. The company adheres to stringent regulatory standards and provides comprehensive support for product registration and logistics across multiple regions.

Mesocaine, a lidocaine hydrochloride preparation, is used in the local and regional anesthesia pathway to achieve reversible nerve block.

- Local anesthesia: provides rapid numbness for minor surgical procedures - Regional anesthesia: enables epidural or spinal block for obstetric and orthopedic surgeries - Pain management: offers short‑term analgesia for acute postoperative pain

Adverse reactions to Mesocaine may range from mild, transient events to rare but serious conditions.

Common Side Effects: - Local irritation at injection site - Transient numbness or tingling - Mild hypotension - Dizziness - Nausea - Headache

Serious or Rare Side Effects: - Seizures - Cardiac arrhythmia or conduction block - Methemoglobinemia - Severe allergic reactions (anaphylaxis) - Respiratory depression - Persistent neurologic deficits

When using Mesocaine, clinicians should observe several safety measures to minimize risk.

- Allergy assessment: confirm no known hypersensitivity to amide‑type local anesthetics - Cardiovascular monitoring: observe heart rate and blood pressure during administration - Hepatic function: adjust dose in patients with severe liver impairment - Conduction disorders: avoid use in patients with significant cardiac conduction abnormalities - Pregnancy considerations: use only if benefit outweighs potential risk, as safety data are limited - Store at room temperature: keep in original container, protect from light and moisture

Mesocaine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may precipitate severe cardiotoxicity - Beta‑blockers (e.g., propranolol): can enhance bradycardia and hypotension

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may increase plasma lidocaine levels - CYP1A2 inducers (e.g., carbamazepine): may reduce effectiveness - Concurrent use of other local anesthetics: risk of cumulative toxicity